AptarGroup Squeezes Out Modest Growth
AptarGroup Inc. (NYSE: ATR) released better-than-expected third-quarter 2017 results on Thursday after the market closed, detailing strong demand across its portfolio of products led by the consumer healthcare and injectables markets. Similar to last quarter, though, AptarGroup's Beauty and Home segment still lagged the others -- though it has a plan to return the troublesome business to profitable growth -- and the company once again issued seemingly conservative earnings guidance for the coming quarter.
With AptarGroup shares down 1.2% on Friday, let's take a deeper look at how the dispensing systems specialist started the second half of the year.
IMAGE SOURCE: APTARGROUP.
Source: Fool.com
Aptargroup Inc. Aktie
133,50 €
-2,42 %
Mehr Buy- als Sell-Zahlen bei Aptargroup Inc. zeigen ein leicht positives Sentiment.
Das Community-Kursziel von 152 € für Aptargroup Inc. deutet auf ein leicht positives Wachstumspotenzial gegenüber 133.5 € hin.
